News from anthera pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 24, 2011, 21:00 ET

Anthera Announces Third Quarter 2011 Financial Report and Conference Call

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Sep 08, 2011, 16:39 ET

Anthera Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application Covering A-002 Plus Statin Compositions

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Jul 29, 2011, 08:00 ET

Anthera Pharmaceuticals Reports 2011 Second Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter ended June 30, 2011....

Jun 08, 2011, 16:00 ET

Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced that it has completed the previously announced underwritten public offering of...

Jun 03, 2011, 09:00 ET

Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the pricing of an underwritten public offering of 6,666,667 shares of its common...

Jun 02, 2011, 16:00 ET

Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced that it intends to offer and sell shares of its common stock in an underwritten...

May 03, 2011, 17:00 ET

Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter ended March 31, 2011....

Apr 18, 2011, 08:00 ET

Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Feb 24, 2011, 17:00 ET

Anthera Pharmaceuticals to Present at the Citi 2011 Global Health Care Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with abnormal...

Feb 23, 2011, 17:00 ET

Anthera Announces Conference Call to Discuss Analytical Method and Timing of Upcoming VISTA-16 Biomarker Analysis

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Feb 23, 2011, 08:00 ET

Anthera Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter and year ended December 31,...

Feb 08, 2011, 17:00 ET

Anthera Pharmaceuticals Names Lawrence Rosania as Vice President of Global Regulatory Affairs and Compliance

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with abnormal...

Feb 01, 2011, 17:00 ET

Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with abnormal...

Jan 06, 2011, 17:00 ET

Anthera Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Dec 14, 2010, 16:15 ET

Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Anthera's Investigational Novel Peptibody Agent

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with abnormal...

Dec 09, 2010, 09:00 ET

Anthera Announces Update Call Regarding Vial Problems

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Dec 07, 2010, 12:00 ET

Varespladib Receives 2010 European Society Pediatric Research Award

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Dec 01, 2010, 17:00 ET

Anthera Pharmaceuticals to Present at the 5th Annual Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Nov 24, 2010, 08:00 ET

Anthera Pharmaceuticals to Present at the 22nd Annual Piper Jaffray Health Care Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Nov 16, 2010, 08:28 ET

Anthera Suspends Enrollment and Dosing in PEARL-SC Clinical Trial to Address Reports of Vial Problems

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...